期刊文献+

替扎尼定联合消痹止痛膏防治硬膜外麻醉后腰背痛疗效观察 被引量:4

下载PDF
导出
摘要 ①目的探讨替扎尼定联合消痹止痛膏防治硬膜外麻醉后腰背痛的临床疗效。②方法将ASAⅡ级进行硬膜外麻醉后患者109例随机分为观察组62例、对照组47例。观察组给予替扎尼定联合消痹止痛膏外敷止痛治疗;对照组给予安慰剂止痛治疗。比较两组术后止痛疗效及药物不良反应。③结果治疗1个月后,两组临床疗效比较有显著性差异(χ2=4.32,P<0.05)。两组治疗过程中均未发生明显的药物不良反应。④结论替扎尼定联合消痹止痛膏能有效预防治疗硬膜外麻醉后腰背痛。
出处 《河北联合大学学报(医学版)》 2012年第3期382-383,共2页 Journal of North China Coal Medical College
  • 相关文献

参考文献3

二级参考文献11

  • 1黄强民.肌筋膜触发点及肌筋膜疼痛综合征[J].颈腰痛杂志,2004,25(5):360-362. 被引量:71
  • 2Blasberg B,Chalmers A.Temporomandibula pain.and dysfunction syndrome associated with generalized musculoskeletal pain:A retrospective study[J].J Rheumatol,1989,16:87-90.
  • 3Fricton JR.Myofascial pain syndrome:characteristics and epidemiology[J].Adv Pain Res Therapy,1990,17:107-127.
  • 4Gerard A.Malanga,MD,Mattews W.Tizanidine Is Effective in the Treatment of Myofaseial Pain Syndrome[J].Pain Physician,2002,5(4):422-432.
  • 5Bennett RM.Emerging concepts in the neurobiology of chronic pain:Evidence of abnormal sensory processing in fibromyalgia[J].Mayo Clin Proc,1999,74:385-398.
  • 6Bendsen L,Jensen R.Amitryptyline reduces myofascial tenderness in patients with chronic tension-type headache[J].Cephalagia,2000,20:603-610.
  • 7Dao TT,Lund JP,Remillard G,et al.Is myofascial pain of the temporal muscles relieed by oral sumatriptan? A cross-over pilot study[J].Pain,1995,62:241-244.
  • 8Forst A.Diclofenac versus Lidocaine as injection therapy in myofascial pain.Scand J Rheumatol.1986,15(2):153-156.
  • 9Mathias BJ,Dillinghan TR,Zeigler DN,et al.Topical capsaicin for chronic neck pain;apilot study[J].Am J Phys Med Rehabil,1995,71:39-44.
  • 10唐功元,张作礼.头颈肿瘤与生存质量[J].国外医学(耳鼻咽喉科学分册),2000,24(1):26-29. 被引量:14

共引文献26

同被引文献31

  • 1杜少芬,李义贤,李喜荣,吴安宏.防治硬膜外麻醉后腰痛的临床观察[J].现代肿瘤医学,2004,12(6):554-555. 被引量:13
  • 2林道炜,许冬妮,彭书,郑晓景.靶控输注异丙酚与吸入异氟醚麻醉在腹腔镜胆囊切除术中的效果[J].中国煤炭工业医学杂志,2005,8(11):1182-1184. 被引量:3
  • 3Edward Morgan GJr,Mikhail MS,Murray MJ,et al.Clinical anesthesiology.3rdedn[M]. NewYork: McGraw-HillMedical Publishing Division, 2002,3 : 275-275.
  • 4Edward Morgan GJr, Mikhail MS, Murray M J, et al. Clinicalanesthesiol- ogy. 3rdedn [ M ]. NewYork:McGraw - HillMedical Publishing Divi- sion,2002. 275 - 275.
  • 5Bissonnette B, Swan H, Ravussin P, et al. NeuroI- eptanesthesia: current status[J]. Can J Anaesth. 1999,46(2) .. 154 - 168.
  • 6Ortolani O, Conti A, Chan YK, et al. Comparison of propo{ol consumption and recovery time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia[J]. Anaesth Intensive Care, 2004,32 (2) : 250 - 255.
  • 7Dahaba AA, Zhong T, Lu HS, et al. Geographicdifferences in the target- controlled infusion esti- mated concentration of propofol: bispectral index re- sponse curves[J]. Can J Anaesth, 2011,58(4) .. 364 - 370.
  • 8Marsh B, White M, Morton N, et al. Pharmacoki- netic model driven infusion of propofol in children [J]. Br J Anaesth, 1991,67(1) .. 41 - 48.
  • 9Struys MM, De Smet T, Depoorter B, et al. Corn parison of plasma compartment versus two methods for effect compartment - - controlled target - con- trolled infusion for propofol [J]. Anesthesiology, 2000,92(2) : 399 - 406.
  • 10Absalom AR, Mani V, De Smet T, et al. Pharmaco- kinetic models for propofoldefining and illuminating the devil in the detail[J]. Br J Anaesth, 2009,103 (1): 26-37.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部